#Coronary Heart Disease (CHD)

[drraghu1]

Comparing Angioplasty to Bypass Surgery: Which Option is Right for You?

Comparing Angioplasty to Bypass Surgery: Which Option is Right for You? Understand the differences between angioplasty and bypass surgery to help determine the best treatment option for your heart condition. Learn about risks, benefits, and recovery. For expert advice, consult Dr. C. Raghu, best Interventional Cardiologist at Yashoda Hospitals, Secunderabad.

Visit Now - https://drraghu.com/hearty-life/comparing-angioplasty-to-bypass-surgery-which-option-is-right-for-you/

[dreamyxangel]

14.07.23

Studied : nutritional anemia, Coronary Heart Disease.

My afternoon went terribly. Couldn't study more than this till 5:00pm.

I just have 2 days left for my 3rd Professional Part-I exams to begin.

I am worrying a lot about how big the syllabus is and I have 4 papers for 4 days straight with no gap days in between at all. Plus, the personal problems and past study mistakes are haunting me.

I just wish to get better and be able to utilize my full potential in studying more and finally finishing off 80% of my syllabus.

EVENING :

Studied-

Diabetes

Hypertension

CHD

Cancer : oral & cervical

Blindness

Short note on Overcrowding

[bpod-bpod]

Bad Timing

Your heart isn't all muscle. Its muscle layer (myocardium) is sandwiched between endocardium and epicardium. Defects in the development of these layers can cause congenital heart disease (CHD), which affects one in 100 newborns. CHD can be caused by a coronary artery fistula (CAF) where a channel, partly comprising smooth muscle, develops between the coronary artery and another part of the heart. A defect in myocardium development may be to blame. Researchers investigated in chick embryos, damaging the myocardium before the epicardium layer forms. The result? Endocardium cells met epicardium cells too early, leading to CAF-like structures. The team then grew quail embryo endometrium (pictured, left) with chick embryo epicardium (right). Fluorescence microscopy revealed that where these different cells met, smooth muscle developed, and where they were apart, smooth muscle was absent. This supports the idea that CAFs form due to the inappropriately timed meeting of these cells.

Written by Lux Fatimathas

Image from work by P. Palmquist-Gomes and colleagues

Department of Animal Biology, Faculty of Sciences, University of Málaga, Málaga, Spain

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in Experimental & Molecular Medicine, January 2023

You can also follow BPoD on Instagram, Twitter and Facebook

[nothinggathers]

"Chest pain was the most common symptom

Chest pain was the most common symptom for both men and women, with 93 per cent of both sexes reporting this symptom. A similar percentage of men and women reported pain that radiated to their left arm (48 percent of men and 49 per cent of women). More women had pain that radiated to their jaw or back and women were also more likely to experience nausea in addition to chest pain (33 per cent vs 19 per cent).

Less typical symptoms, such as epigastric pain (heartburn), back pain, or pain that was burning, stabbing or similar to that of indigestion, were more common in men than women (41 per cent in men vs 23 per cent in women).

Previous research has suggested that women and men report different heart attack symptoms. However, the symptoms were often recorded after a heart attack diagnosis was confirmed, which may introduce bias. This study aimed to avoid this by asking an independent research nurse to interview and record the symptoms of all patients arriving at the ED with a possible heart attack before they were given a diagnosis."

Key symptoms are still chest pain, and shortness of breath. Women are more likely to get pain radiating into their jaw or back and nausea but this is still only 33% of women.

BUT

There may be differences in how women of various ethnicities experience symptoms of heart attack both before and during the events.

"Shortness of breath was the most frequently reported symptom (n=798, 62.8%) followed by weakness (n=697, 54.9%), unusual fatigue (n=613, 48.3%), dizziness (n=559, 44%), and cold sweat (n=508, 40%). Using Chi-square tests we examined differences among racial groups. We found significant differences (p<0.01) on 22 of the 37 acute symptoms (see Table 6). ... Black women reported 2 generalized symptoms, feeling hot and flushed and indigestion, significantly more frequently than Hispanic and White women. Hispanics and Whites did not report any generalized symptoms significantly more often than Blacks. White women reported the least number of generalized symptoms except for indigestion. ... Hispanic women had the highest rates of pain/discomfort in all locations, except for pain in the left breast. White women reported pain/discomfort in 4 locations significantly more often than Black women (back, generalized chest, both arms and jaw/teeth); but less frequently than Hispanic women."

I highly advise you check the article, the tables are very in depth and break things down by where exactly pain may be localised. It also goes into the experience of the pre-heart attack symptoms for these women, the most common ones being unusual fatigue and sleep disturbance, both of which were experienced more commonly by black and hispanic women in the days preceding a heart attack than by white women.

"Minority women reported significantly more acute symptoms than White women, but regardless of race, shortness of breath was the most frequently reported individual acute symptom.

...

After we combined all locations of acute chest pain/discomfort into a single symptom, it became the most frequent symptom for Hispanics and Whites but not for Blacks. Although the majority reported some type of chest symptoms during the actual AMI, 28% of Hispanic, 38% of Black, and 42% of White women did not report any chest pain/discomfort. Their lack of acute chest pain/discomfort is important since inappropriate or missed diagnosis in women is frequently attributed to lack of chest pain on presentation."

The key, as with all things like this, is knowing the symptoms and not waiting to act on them because you don't have one you expect.

Don't assume you're not having a heart attack if you don't have chest pain, but also don't insist on waiting for jaw or neck pain just because you have an oestrogen based endocrine system.

Heart attacks symptoms are different for women. I recently learned this. 

[ayurvedhospital]

Coronary Heart Disease Treatment in Pune

The symptoms of coronary heart disease can be managed with treatment, and the likelihood of developing new issues is decreased. Effective management of CHD can be achieved through a mix of medication, lifestyle modifications, and, occasionally, surgery. The symptoms of CHD can be lessened with effective therapy, and the heart's performance can be enhanced. Get the best Coronary Heart Disease Treatment in Pune. Visit us: https://www.ayurvedhospital.com/coronary-heart-disease.html

[jayanthitbrc]

Global Drug Eluting Stent Market Overview 2024: Size, Growth Rate, and Segments

The drug eluting stent global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Drug Eluting Stent Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The drug eluting stent market size has grown strongly in recent years. It will grow from $7.05 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to the need for improved treatment options, clinical evidence, regulatory approval, healthcare economics, and guidelines and recommendations.

The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $10.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to an aging population and chronic disease burden, the expansion of indications, healthcare reimbursement policies, global market expansion, and patient-centered care. Major trends in the forecast period include personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report

Scope Of Drug Eluting Stent MarketThe Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Drug Eluting Stent Market Overview

Market Drivers -The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stent market going forward. Coronary heart disease (CHD) is a condition where the coronary arteries become narrowed or blocked due to plaque buildup, potentially leading to severe complications such as a heart attack or chest pain. Coronary heart disease is increasing due to sedentary lifestyles, poor diets, aging populations, and heightened awareness. Drug-eluting stents (DES) benefit coronary heart disease by effectively opening narrowed or blocked coronary arteries and releasing medication that helps prevent re-narrowing (restenosis) of the artery. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a US-based governmental organization, the percentage of coronary heart disease in adults aged 18 and over in 2020 was 4.6%, which increased to 4.9% in 2022. The rising burden of coronary heart disease is expected to propel the growth of the drug-eluting stench market.

Market Trends - Companies operating in the drug-eluting stent market are focusing on developing innovative delivery systems, such as the dual-layer balloon, to improve patient outcomes and advance the field of interventional cardiology. A dual-layer balloon in a drug-eluting stent system enhances precision in drug delivery and stent deployment by providing better control and uniform drug application to the arterial wall. For instance, in August 2022, Medtronic Plc, an Ireland-based provider of medical supplies, launched Onyx Frontier, the latest generation of drug-eluting coronary stent systems designed to enhance delivery systems that build upon the acute performance and clinical data from the previous generation of Resolute Onyx DES. The Onyx Frontier DES leverages the same best-in-class stent platform as Resolute Onyx, with a broad size matrix to treat patients ranging from 2.0mm to 5.0mm in diameter. The Onyx Frontier DES incorporates notable design enhancements, such as a groundbreaking dual-layer balloon, reduced crossing profile, and improved catheter flexibility. These improvements yield a 16% increase in deliverability over the prior Resolute Onyx DES generation, all while preserving radial strength.

The drug eluting stent market covered in this report is segmented –

1) By Product: Polymer-Based, Polymer-Free 2) By Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Other Drugs 3) By Scaffold: Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Other Scaffolds 4) By Application: Coronary Diseases, Peripheral Vascular Diseases 4) By End-User: Hospitals, Specialty Clinics

Get an inside scoop of the drug eluting stent market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15557&type=smp

Regional Insights - North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

Table of Contents 1. Executive Summary 2. Drug Eluting Stent Market Report Structure 3. Drug Eluting Stent Market Trends And Strategies 4. Drug Eluting Stent Market – Macro Economic Scenario 5. Drug Eluting Stent Market Size And Growth ….. 27. Drug Eluting Stent Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[market-insider]

Functional Shots Market In-Depth Study: Evaluating Market Size, Share, Growth Forecast

The global functional shots market size is expected to reach USD 2.06 billion by 2030, exhibiting a CAGR 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising consumer awareness regarding preventive healthcare-due to the increasing prevalence of various diseases and fast-paced, hectic lifestyles-is driving individuals to seek convenient and nutritious food options. Functional shots are developed using various natural and functional ingredients, such as adaptogens, antioxidants, and vitamins, which help meet the growing demand for preventive health measures and wellness solutions.

According to an article by BNP Media’s Beverage Industry, rising consumer awareness is driving significant growth in the gut-health beverages segment. There is ample opportunity to educate consumers about the distinctions between pro- and prebiotics, allowing brands to deepen consumer understanding and foster informed choices among those seeking digestive health solutions. For instance, in November 2019, Good Culture, a dairy brand of clean-label products, announced the launch of its Wellness Probiotic Gut Shots to gain an advantage in the emerging market of probiotic shots by merging them with functional ingredients.

Functional Shots Market Report Highlights

Energy functional shots captured 40.6% of global revenue in 2023. This strong demand is driven by rising health awareness, the growing need for quick energy boosts, and the popularity of convenient, portable beverage options.

Sales of functional shots through online channels are projected to grow at a compound annual growth rate (CAGR) of 20.6% from 2024 to 2030. This growth is fueled by consumers' increasing preference for the convenience and ease of online shopping, which is boosting the online segment within the market.

The market in North America held 31.7% of global revenue in 2023. The market's growth in this region is largely driven by the increasing prevalence of physical activity, as more individuals adopt active lifestyles and seek convenient, effective solutions to support their health and fitness goals.

For More Details or Sample Copy please visit link @: Functional Shots Market Report

Consumer trends and preferences in the market have undergone significant shifts in recent years, driven by a growing emphasis on holistic wellness and personalized nutrition. Consumers increasingly seek functional shots formulated with natural, plant-based ingredients, free from artificial additives and preservatives. They are also gravitating toward functional shots such as ginger shots and beetroot shots that offer multiple health benefits, such as immune support, stress relief, and cognitive enhancement. These trends reflect a desire for convenient solutions to address various aspects of consumer well-being.

According to the National Center for Biotechnology Information (NCBI), ginger exhibits promising preventive properties against chronic diseases like hypertension and coronary heart disease (CHD) while also contributing to enhancing overall immune system function. A study by NCBI indicates that increasing daily ginger intake by 1g as part of a balanced diet may offer these preventive advantages. Moreover, ginger is an antibacterial and antiviral agent, an antioxidant, an anti-inflammatory compound, an antinausea agent, and an anticancer agent, further supporting its role in promoting well-being and disease prevention.

List of Key Players in the Functional Shots Market

Living Essentials Marketing, LLC

For Goodness Shakes Ltd

Unrooted Drinks

Beet It Sport

PepsiCo (KeVita)

Arizona Beverages USA

Suja Life, LLC.

Hawaiian OLA

Pressed Juicery

For Customized reports or Special Pricing please visit @: Functional Shots Market Analysis Report

We have segmented the global functional shots market based on product, material, distribution channel, and region.

[nobertsales]

National Nut Day

#Nuts are a highly prized food and energy source and are a primary source of nutrients for both humans and wildlife. Many of them are used in cooking, eaten raw, sprouted, or roasted as a snack food, and pressed for oil that is used in cookery and cosmetics. The fats found in nuts, for the most part, are unsaturated fats, including monounsaturated fats.

Many nuts are excellent sources of vitamins E and B2. They are also rich in protein, folate fiber, and essential minerals such as magnesium, phosphorus, potassium, copper, and selenium.

Several studies have shown that those who consume nuts regularly are less likely to suffer from coronary heart disease (CHD). It was in 1993 that nuts were first linked to protection against CHD. Since that time, many clinical trials have found that the consumption of various nuts, such as almonds and walnuts, can lower serum LDL cholesterol concentrations.

One study has shown that people who ate nuts lived two to three years longer than those who did not. Those who were consuming nuts may have been eating less junk food leading to a longer lifespan.

Nuts in their raw form retain the most nutritional benefit, too. However you celebrate the day, though, be sure to enjoy snacking on your favorite nut!

🌰 #NationalNutDay #FoodOfTheDay @NobertSales #NobertSales #Food #FoodSolutions #FoodService #FoodServiceSolutions #FoodSales #WeKnowFood #FoodConsultant #FoodDude 

[tods-drtulip-blog]

Coronary Artery Disease: The Silent Blockage Leading to Heart Attacks

Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease, occurs when plaque buildup narrows or blocks the arteries that supply oxygen-rich blood to the heart, often without noticeable symptoms until a blood clot forms and causes a heart attack. This condition can develop over many years and is often referred to as a "silent killer."

Coronary artery disease (CAD) occurs when the arteries supplying oxygen-rich blood to the heart become narrowed or blocked due to a buildup of plaque, which includes cholesterol. This buildup restricts blood flow to the heart. Think of it like two lanes of traffic merging into one due to road construction—traffic still moves, but more slowly. In CAD, you might not notice any symptoms until the plaque causes a blood clot, which is like a barrier blocking the road. This blockage stops blood flow to the heart, leading to a heart attack. CAD can be present for many years without any symptoms, which is why it’s often called a “silent killer.” It is also known as coronary heart disease (CHD) or ischemic heart disease, and is what many people refer to when they talk about “heart disease.” Read more….

[codeshive]

Stat 432 Homework 8 solved

Question 1 (logistic regression) [5 points] We consider a logistic regression problem using the South Africa heart data as a demonstration. The goal is to estimate the probability of chd, the indicator of coronary heart disease. The following code is used to prepare the data and fit the logistic regression. library(ElemStatLearn) data(SAheart) heart = SAheart heart$famhist =…

[medicalhealth10]

Understanding Coronary Heart Disease (CHD): A Growing Concern

Coronary Heart Disease (CHD) remains one of the leading causes of death globally, affecting millions each year. It occurs when the coronary arteries, which supply blood to the heart, become narrowed or blocked due to the buildup of plaque, leading to reduced blood flow. This can result in chest pain, heart attacks, or other severe complications.

In our latest article on CHD, we dive deep into the causes, symptoms, and prevention strategies for this life-threatening condition. We explore how lifestyle factors such as poor diet, lack of exercise, smoking, and stress contribute to the development of CHD. Understanding these risk factors is the first step towards making healthier choices that can protect your heart.

We also provide valuable insights into the latest treatment options, including medication, surgical interventions, and lifestyle changes that can help manage the condition effectively. Whether you're at risk or supporting a loved one, our article offers practical tips on managing heart health, recognizing warning signs, and when to seek medical advice.

Read our comprehensive guide to stay informed and take proactive steps toward a healthier heart. Empower yourself with the knowledge to combat CHD and lead a heart-healthy life. Don't miss out on this crucial information—check out the full article today! Coronary Heart Disease (CHD)- Medical & Health

Coronary Heart Disease (CHD)- Medical & Health

coronary heart disease, coronary heart disease symptoms, treatment for coronary heart disease, coronary heart disease medications, CAD, CHD, IHD,

[ayurvedpanchkarma]

Coronary Heart Disease Treatment in Pune

The symptoms of coronary heart disease (CHD) can be managed with treatment, and the likelihood of developing new issues is decreased. Effective management of CHD can be achieved through a mix of medication, lifestyle modifications, and, occasionally, surgery. The symptoms of CHD can be lessened with effective therapy, and the heart's performance can be enhanced. Get the best Coronary Heart Disease Treatment in Pune. https://www.ayurvedhospital.com/coronary-heart-disease.html

[ayurvedaawareness]

Ayurveda and Yoga Therapy for Heart Disease

Heart disease, or Cardiovascular Disease (CVD), refers to a variety of conditions affecting the heart's structure and function. Here are some common types of heart disease:

Coronary Heart Disease (CHD): Also known as ischemic heart disease (IHD), atherosclerosis, or coronary artery disease (CAD), this condition is caused by plaque buildup in the heart’s arteries, leading to hardened arteries.

Heart Attack (Myocardial Infarction)

Heart Failure

Arrhythmias: Abnormal heart rhythms.

Aneurysm: A bulge caused by weakening of the heart muscle or arteries.

Rheumatic Heart Disease: Caused by rheumatic fever, primarily affecting the heart valves.

Congenital Heart Disease: Defects or malformations in the heart or blood vessels present from birth.

Cardiomyopathy: Hardening or weakening of the heart muscles.

Myocarditis: Inflammation and infiltration of the myocardium with necrosis and degeneration.

Pericarditis: Inflammation of the pericardium.

Valvular Diseases: Conditions related to the heart valves.

According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths annually. In Australia, heart disease is the leading single cause of death, with 18,590 deaths attributed to it in 2017, meaning one Australian dies from heart disease every 28 minutes. The Centers for Disease Control and Prevention (CDC) in the USA also reports that approximately every 40 seconds, an American has a heart attack, and heart disease accounts for 1 in every 4 deaths in the country.

Causes and Risk Factors

According to the World Health Organization, the most important behavioral risk factors for heart disease and stroke include an unhealthy diet, physical inactivity, tobacco use, and harmful alcohol use. Most cardiovascular diseases can be prevented by addressing these risk factors.

Role of Yoga, Ayurveda, and Natural Therapies

In the prevention and management of cardiovascular diseases (CVDs), Yoga, Ayurveda, and natural therapies play an essential role.

Ayurveda and Yoga

Yoga and Ayurveda are interrelated branches of the same tradition, forming a comprehensive approach for optimal health, vitality, and higher awareness. They address not only specific therapies but also the root causes of diseases, promoting overall health and well-being.

Ayurveda in a Modern Context

The rise of chronic and non-communicable diseases (NCDs) like diabetes, obesity, and heart diseases is often linked to stress, improper diet, and a sedentary lifestyle. Ayurveda supports physical, mental, and social health, improving disease symptoms and quality of life through daily and seasonal routines, healthy eating habits, and appropriate exercise. Research supports the effectiveness of Ayurveda in managing heart disease by reducing stress and hypertension, major contributors to heart disease.

Yoga Therapy in a Modern Context

Research indicates that yoga significantly benefits heart health by reducing stress and hypertension, improving circulation, and enhancing overall cardiovascular function. Yoga can lower blood pressure, cholesterol, blood glucose levels, and heart rate, reducing the risk of hypertension, stroke, and heart disease.

The Emotional Heart

The heart has long been a symbol of life, love, joy, courage, and faith. Reducing emotional stress and fostering joy and peace are crucial for heart health. Practices such as relaxation, meditation, and Yoga Nidra are essential components of a yoga therapy protocol for heart disease.

What Ayurveda and Yoga Offerings for Heart Disease?

Relaxation, Meditation, Yoga Nidra

Stress reduction through relaxation, Yoga Nidra, and meditation is crucial in managing heart disease.

Mantra Chanting

Studies show that mantra chanting improves quality of life, mood, and general well-being, offering measurable physiological and psychological benefits.

Asanas, Bandhas, and Pranayama

Gentle asanas, avoiding strain and discomfort, benefit heart patients by extending the spine and expanding the chest. Inverted poses and strong postures are generally contraindicated for those with high blood pressure and heart disease. Practicing gentle pranayama exercises, like left nostril breathing, anulom vilom, and ujjayi pranayama without kumbhak, is beneficial.

Ayurvedic Herbs and Treatments

Ayurvedic treatments such as snehana massage, hrud basti, and shirodhara can de-stress and strengthen the heart. Herbs like Arjun and Ashwagandha are particularly useful but should be taken under practitioner guidance.

Mudras

Hridaya mudra (heart gesture) or apana vayu mudra are recommended for heart health.

Foods

A balanced diet high in fibers and low in fats and carbohydrates, typically plant-based and low-fat (sattvic diet), is recommended. Foods to avoid include non-vegetarian food, dairy products, oily and spicy foods, refined and processed foods, fast food, and excessive salt. By integrating Ayurveda and Yoga into daily routines, individuals can significantly improve their heart health and overall well-being.

Contact Us:

Address: Ayurveda Awareness Centre (AAC) 14 Cunningham Street, Applecross, WA, 6153, Australia

Website: www.ayurveda-awareness.com.au

Contact No.: +61893154935

Email: info@ayurveda-awareness.com.au

Follow Us on:

Facebook: https://www.facebook.com/AyurvedaAwareness

Instagram:https://www.instagram.com/ayurvedaawareness/

Youtube:https://www.youtube.com/@ayurvedaawareness

[chuckschmalzried]

Sugar Not Fat is More Responsible for Heart Attacks Doctors Says

Sugar, Not Fat, is More Responsible for Heart Attacks, Doctors Says https://theheartysoul.com/sugar-not-fat-is-more-responsible-for-heart-attacks/ Coronary Heart Disease (CHD) is responsible for one in every four deaths in the United States, making it the number one killer of Americans every year [1]. We know that people who are diabetic, who are overweight or obese, who eat an unhealthy diet, don’t exercise and consume excessive amounts of alcohol are at a […] The post Sugar, Not Fat, is More Responsible for Heart Attacks, Doctors Says appeared first on The Hearty Soul. via The Hearty Soul https://theheartysoul.com/ June 24, 2024 at 09:13AM

[dr-hartmuth-bittner]

A Brief Overview of Circumstances that Necessitate Heart Surgery

Heart, cardiac, and cardiovascular surgery refers to any surgery involving the heart or connected blood vessels. Surgeons perform such operations to treat complications of ischemic heart disease (IHD), abnormal heart rhythms, and congenital heart disease (CHD).

Ischemic heart disease or coronary artery disease leads to reduced blood flow to the cardiac muscle due to atherosclerotic plaque build-up in the heart’s arteries. IHD remains the most common cardiovascular disease. Individuals may experience various symptoms, such as chest pain or discomfort that travels to the arm, shoulder, back, jaw, or neck. IHD types include unstable angina, stable angina, and myocardial infarction.

Congenital heart defect or congenital heart anomaly stems from birth defects that affect the heart's structure or critical vessels. A cardiovascular disease, CHD has varied signs and symptoms based on the specific defect type. Moreover, some symptoms pose life-threatening risks while others do not. Therefore, individuals benefit from annual checkups to monitor risk and progress.